EVH logo

EVH

Evolent Health, Inc.NYSEHealthcare
$2.25+1.35%OpenMarket Cap: $251.2M

As of 2026-04-06

Valuation

View Details

P/E (TTM)

PEG

P/B

0.62

P/S

0.13

EV/EBITDA

-3.01

DCF Value

$-310.01

FCF Yield

1.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

15.1%

Operating Margin

-0.6%

Net Margin

-28.5%

ROE

-69.2%

ROA

-86.2%

ROIC

-0.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$468.7M$-429.1M$-3.76
FY 2025$1.88B$-534.5M$-5.07
Q3 2025$479.5M$-20.9M$-0.24
Q2 2025$444.3M$-19.9M$-0.44

Analyst Ratings

View All
OppenheimerOutperform
2026-03-02
CitigroupBuy
2026-02-26
UBSBuy
2026-02-26
Truist SecuritiesBuy
2026-02-26
BTIGBuy
2026-02-25

Trading Activity

Insider Trades

View All
Blackley Sethdirector, officer: Chief Executive Officer
SellWed Mar 04
Blackley Sethdirector, officer: Chief Executive Officer
SellWed Mar 04
Blackley Sethdirector, officer: Chief Executive Officer
SellWed Mar 04
Blackley Sethdirector, officer: Chief Executive Officer
SellWed Mar 04
Blackley Sethdirector, officer: Chief Executive Officer
SellWed Mar 04

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

0.37

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Peers